Verisante Technology, Inc.

Sector: Specialty Hospitals Except Psychiatric Region: Canada

Exchange/Ticker: TSX Venture Exchange: VRS | OTC Bulletin Board: VRSEF

Company Description

Verisante Technology, Inc. a medical device company, which is engaged in development, regulatory, production and commercialization of skin cancer detection systems. Its products include Verisante Aura and Verisante Core. The Verisante Aura is a multimodality imaging and spectroscopy system designed to aid in the early detection of skin cancer. The Verisante Core is designed to aid in the early detection of other cancers, which includes lung, colon and cervical. The company was founded by Thomas A. Braun on March 7, 2006 and is headquartered in Vancouver, Canada.

×We're Sorry! We do not have any documents available for this company. Tell us you want them!

Featured Company

Aberdeen Private Equity Fund Ltd.

London, Guernsey , GG

**Objective of Aberdeen Private Equity Fund** The investment objective of the Company is to generate long-term capital gains. … Learn more →